Autosomal Dominant Hypercholesterolemia 3
1 drug in active Autosomal Dominant Hypercholesterolemia 3 trials · Updated 18 Nov 2026
Furthest along
1 approved
Next Phase 3 result
None yet
Drugs
1
In active trials, any stage
Trials
1 active
No sub-diseases
Drugs1
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Amgen · Public AMGN |
On the market | 30 Apr 2029Phase 4 trial completes | ||
| How it works | An antibody | ||||
| Next date | 30 Apr 2029 · Phase 4 trial completes | ||||
| Also tested for | Coronary Artery Disease, Hypercholesterolemia and 2 more | ||||
| Open drug page | |||||
About
- Summary
- 1 drug is in active Autosomal Dominant Hypercholesterolemia 3 trials. Updated 18 Nov 2026.
- Registry term
- Hypercholesterolemia, Autosomal Dominant, 3
- Counts
- Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026